Tymlos 80 μg/40 μL, solution injectable en stylo prérempli

7680692460011 CH-69246 Lösung
Tymlos 80 μg/40 μL, solution injectable en stylo prérempli
Tymlos 80 μg/40 μL, solution injectable en stylo prérempli
Tymlos 80 μg/40 μL, solution injectable en stylo prérempli
1 / 3
google

Article details

Package size
1
Selling units
1
Measure
Stück
Galenic form
Lösung
Galenic group
unbekannt

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
28/11/2024
Patient information leaflet
Français
28/11/2024
Patient information leaflet
Italien
28/11/2024
Summary of Product Characteristics
Allemand
28/11/2024
Summary of Product Characteristics
Français
28/11/2024
Summary of Product Characteristics
Italien
28/11/2024

Detailed composition

Substance Quantity Type Category
(N/A)
2000.0 UG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
0.9 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance Konservierungsstoff (Conservateur)
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 325.70
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/05/2025

Authorization holder

Labatec Pharma SA

1217 Meyrin

Authorization information

Swissmedic authorization number
69246
Drug name
Tymlos, solution injectable en stylo prérempli
Galenic form
INLFP
ATC Code
H05AA04
Authorization status
Z
Dispensing category
B
First authorization
07/03/2024
Authorization expiration date
06/03/2029
IT Number
07.99.0.
Domain
Human medicine

Package details

Description (FR)
TYMLOS sol inj 80 mcg/0.04ml stylo pré 0.04 ml
Description (DE)
TYMLOS Inj Lös 80 mcg/0.04ml Fertpen 0.04 ml
Market launch
07/03/2024
Narcotic (BTM)
No